China Journal of Leprosy and Skin Diseases ›› 2021, Vol. 37 ›› Issue (1): 30-31.doi: 10.12144/zgmfskin202101030

• Articles • Previous Articles     Next Articles

A child with psoriasis successfully treated with interleukin-17A antagonist and literature review

SUN Yonghu, ZHANG Furen   

  1. Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250022, China
  • Online:2021-01-15 Published:2021-01-05
  • Contact: ZHANG Furen, E-mail: zhangfuren@hotmail.com

PDF (PC)

243

Like

Abstract: Currently, the biological agents for the treatment of psoriasis are mostly designed for adults, and there is a lack of clinical research on the standardized treatment of children's psoriasis. We reported a 6-year-old child with psoriasis who was successfully treated with interleukin-17A antagonist and summarized the current biologic agents approved for the clinical treatment for pediatric psoriasis.

Key words: pediatric psoriasis, biological agents, IL17A